U.S. Pharmaceuticals & Biotech Aandelen - Grootste verliezers vandaag

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED May 26, 2026

Ontdek de U.S. (NYSE en NASDAQ) Grootste verliezers van vandaag. Deze Pharmaceuticals & Biotech Stocks hebben de grootste daling in Market Cap gezien ten opzichte van de vorige handelsdag.

710 bedrijven

Bedrijf	Laatste prijs	1D Terugkeer	1 J Rendement	Marktkapitalisatie	Doel analisten	Waardering	Groei	Div Opbrengst
JNJ	US$230.18	-1.8%	50.2%	US$564.1b	US$252.96	26.3	8.3%	2.3%
MRK	US$119.72	-2.2%	54.3%	US$302.3b	US$129.74	33.1	21.2%	2.8%
ABBV	US$213.12	-1.2%	14.8%	US$381.1b	US$252.90	104.7	25.2%	3.2%
BMY	US$58.03	-2.4%	23.8%	US$121.4b	US$62.96	16.3	-2.3%	4.3%
AMGN	US$335.94	-1.0%	20.2%	US$183.1b	US$352.23	23.2	8.6%	3.0%
IQV	US$162.00	-3.5%	15.3%	US$28.0b	US$228.60	19.5	13.1%	n/a
ONC	US$302.44	-2.5%	25.8%	US$33.6b	US$411.51	65.5	29.0%	n/a
GILD	US$133.73	-0.5%	22.6%	US$166.8b	US$157.83	18.0	21.1%	2.5%
RGC	US$24.31	-5.8%	84.2%	US$12.8b	n/a	9858.3	n/a	n/a
ASND	US$239.65	-3.0%	n/a	US$15.3b	US$297.63	25.8	16.9%	n/a
ZTS	US$80.23	-1.3%	-51.7%	US$34.1b	US$124.59	12.6	5.2%	2.6%
VTRS	US$16.26	-2.3%	89.1%	US$19.4b	US$18.06	1.3	50.9%	3.0%
REGN	US$634.62	-0.7%	5.2%	US$65.0b	US$833.31	14.6	11.7%	0.6%
RPRX	US$53.86	-1.2%	64.8%	US$31.4b	US$59.25	28.9	38.8%	1.7%
WAT	US$338.64	-1.1%	-5.5%	US$33.6b	US$400.52	73.9	25.0%	n/a
NTRA	US$200.91	-1.1%	27.8%	US$29.1b	US$260.89	11.5	62.7%	n/a
PFE	US$25.85	-0.2%	9.5%	US$147.6b	US$29.19	19.7	-1.0%	6.7%
BBIO	US$67.73	-2.0%	104.6%	US$13.5b	US$102.47	22.9	65.2%	n/a
ALNY	US$295.50	-0.7%	1.9%	US$39.7b	US$445.81	73.3	28.3%	n/a
BMRN	US$52.88	-2.2%	-9.0%	US$10.5b	US$87.85	38.0	24.7%	n/a
LLY	US$1,064.74	-0.02%	46.8%	US$949.7b	US$1,215.10	37.6	16.7%	0.6%
ICLR	US$113.85	-2.5%	-13.3%	US$8.9b	US$132.60	14.5	3.7%	n/a
ROIV	US$29.67	-1.0%	175.7%	US$21.5b	US$39.04	2583.2	50.0%	n/a
CGON	US$61.89	-3.7%	142.5%	US$5.7b	US$90.29	1076.5	60.1%	n/a

Page 1 of 30